These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 17015867

  • 21. Soluble Urokinase-Type Plasminogen Activator Receptor Plasma Concentration May Predict Susceptibility to High Altitude Pulmonary Edema.
    Hilty MP, Zügel S, Schoeb M, Auinger K, Dehnert C, Maggiorini M.
    Mediators Inflamm; 2016; 2016():1942460. PubMed ID: 27378823
    [Abstract] [Full Text] [Related]

  • 22. Increased hepcidin levels in high-altitude pulmonary edema.
    Altamura S, Bärtsch P, Dehnert C, Maggiorini M, Weiss G, Theurl I, Muckenthaler MU, Mairbäurl H.
    J Appl Physiol (1985); 2015 Feb 01; 118(3):292-8. PubMed ID: 25525212
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of Dexamethasone in Preventing Acute Mountain Sickness in COPD Patients: Randomized Trial.
    Furian M, Lichtblau M, Aeschbacher SS, Estebesova B, Emilov B, Sheraliev U, Marazhapov NH, Mademilov M, Osmonov B, Bisang M, Ulrich S, Latshang TD, Ulrich S, Sooronbaev TM, Bloch KE.
    Chest; 2018 Oct 01; 154(4):788-797. PubMed ID: 29909285
    [Abstract] [Full Text] [Related]

  • 24. [Your patient wants to go to the mountains. You protect him from mountain sickness and altitude edema].
    MMW Fortschr Med; 2005 Apr 07; 147(14):4-5. PubMed ID: 15887670
    [No Abstract] [Full Text] [Related]

  • 25. Remote ischemic preconditioning does not prevent acute mountain sickness after rapid ascent to 3,450 m.
    Berger MM, Macholz F, Lehmann L, Dankl D, Hochreiter M, Bacher B, Bärtsch P, Mairbäurl H.
    J Appl Physiol (1985); 2017 Nov 01; 123(5):1228-1234. PubMed ID: 28798201
    [Abstract] [Full Text] [Related]

  • 26. Does High Alveolar Fluid Reabsorption Prevent HAPE in Individuals with Exaggerated Pulmonary Hypertension in Hypoxia?
    Betz T, Dehnert C, Bärtsch P, Schommer K, Mairbäurl H.
    High Alt Med Biol; 2015 Dec 01; 16(4):283-9. PubMed ID: 26258866
    [Abstract] [Full Text] [Related]

  • 27. Prevention of high-altitude pulmonary edema by nifedipine.
    Bärtsch P, Maggiorini M, Ritter M, Noti C, Vock P, Oelz O.
    N Engl J Med; 1991 Oct 31; 325(18):1284-9. PubMed ID: 1922223
    [Abstract] [Full Text] [Related]

  • 28. Endothelial selectins in acute mountain sickness and high-altitude pulmonary edema.
    Grissom CK, Zimmerman GA, Whatley RE.
    Chest; 1997 Dec 31; 112(6):1572-8. PubMed ID: 9404756
    [Abstract] [Full Text] [Related]

  • 29. Hypoxia impairs systemic endothelial function in individuals prone to high-altitude pulmonary edema.
    Berger MM, Hesse C, Dehnert C, Siedler H, Kleinbongard P, Bardenheuer HJ, Kelm M, Bärtsch P, Haefeli WE.
    Am J Respir Crit Care Med; 2005 Sep 15; 172(6):763-7. PubMed ID: 15947284
    [Abstract] [Full Text] [Related]

  • 30. Exaggerated pulmonary hypertension is not sufficient to trigger high-altitude pulmonary oedema in humans.
    Sartori C, Allemann Y, Trueb L, Lepori M, Maggiorini M, Nicod P, Scherrer U.
    Schweiz Med Wochenschr; 2000 Mar 18; 130(11):385-9. PubMed ID: 10774001
    [Abstract] [Full Text] [Related]

  • 31. Phosphodiesterase type 5 inhibitors in the treatment and prevention of high altitude pulmonary edema.
    Bates MG, Thompson AA, Baillie JK.
    Curr Opin Investig Drugs; 2007 Mar 18; 8(3):226-31. PubMed ID: 17408118
    [Abstract] [Full Text] [Related]

  • 32. High-altitude pulmonary edema: from exaggerated pulmonary hypertension to a defect in transepithelial sodium transport.
    Scherrer U, Sartori C, Lepori M, Allemann Y, Duplain H, Trueb L, Nicod P.
    Adv Exp Med Biol; 1999 Mar 18; 474():93-107. PubMed ID: 10634996
    [Abstract] [Full Text] [Related]

  • 33. Low pulmonary diffusing capacity in subjects with acute mountain sickness.
    Ge RL, Matsuzawa Y, Takeoka M, Kubo K, Sekiguchi M, Kobayashi T.
    Chest; 1997 Jan 18; 111(1):58-64. PubMed ID: 8995993
    [Abstract] [Full Text] [Related]

  • 34. Stress Doppler echocardiography for identification of susceptibility to high altitude pulmonary edema.
    Grünig E, Mereles D, Hildebrandt W, Swenson ER, Kübler W, Kuecherer H, Bärtsch P.
    J Am Coll Cardiol; 2000 Mar 15; 35(4):980-7. PubMed ID: 10732898
    [Abstract] [Full Text] [Related]

  • 35. Patent foramen ovale and high-altitude pulmonary edema.
    Allemann Y, Hutter D, Lipp E, Sartori C, Duplain H, Egli M, Cook S, Scherrer U, Seiler C.
    JAMA; 2006 Dec 27; 296(24):2954-8. PubMed ID: 17190896
    [Abstract] [Full Text] [Related]

  • 36. The effects of a 5-lipoxygenase inhibitor on acute mountain sickness and urinary leukotriene e4 after ascent to high altitude.
    Grissom CK, Richer LD, Elstad MR.
    Chest; 2005 Feb 27; 127(2):565-70. PubMed ID: 15705997
    [Abstract] [Full Text] [Related]

  • 37. [Changes of pulmonary diffusing capacity in subjects with acute mountain sickness].
    Chen Q, Ge R, Ruan Z.
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Feb 27; 23(2):101-3. PubMed ID: 11778493
    [Abstract] [Full Text] [Related]

  • 38. High altitude pulmonary edema: a pressure-induced leak.
    Dehnert C, Berger MM, Mairbäurl H, Bärtsch P.
    Respir Physiol Neurobiol; 2007 Sep 30; 158(2-3):266-73. PubMed ID: 17602898
    [Abstract] [Full Text] [Related]

  • 39. Reducing the incidence of high-altitude pulmonary edema.
    Pun M, Ghimire LV.
    Ann Intern Med; 2007 Apr 17; 146(8):613; author reply 613-4. PubMed ID: 17438324
    [No Abstract] [Full Text] [Related]

  • 40. Glucocorticoids as prophylaxis against acute mountain sickness.
    Basu M, Sawhney RC, Kumar S, Pal K, Prasad R, Selvamurthy W.
    Clin Endocrinol (Oxf); 2002 Dec 17; 57(6):761-7. PubMed ID: 12460326
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.